Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2018, Article ID 9281918, 4 pages
https://doi.org/10.1155/2018/9281918
Case Report

Acute Left Internal Carotid Artery and Right Popliteal Artery Occlusion Related to Cisplatin-Gemcitabine Based Chemotherapy

1Department of Neurology, Einstein Medical Center, Philadelphia, USA
2Division of Hematology and Medical Oncology, Einstein Medical Center, Philadelphia, USA
3Department of Medicine, Einstein Medical Center, Philadelphia, USA

Correspondence should be addressed to Andrew Tiu; ude.nietsnie@erdnauit

Received 27 September 2018; Accepted 3 December 2018; Published 17 December 2018

Academic Editor: Samuel T. Gontkovsky

Copyright © 2018 Saman Zafar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. B. Navi, A. S. Reiner, H. Kamel et al., “Risk of arterial thromboembolism in patients with cancer,” Journal of the American College of Cardiology, vol. 70, no. 8, pp. 926–938, 2017. View at Publisher · View at Google Scholar
  2. M. Jafri and A. Protheroe, “Cisplatin-associated thrombosis,” Anti-Cancer Drugs, vol. 19, no. 9, pp. 927–929, 2008. View at Publisher · View at Google Scholar
  3. T. Etgen, G. Weidenhöfer, and T. Kubin, “Cisplatin-associated occlusion of the internal carotid artery,” Onkologie, vol. 32, no. 12, pp. 754–757, 2009. View at Publisher · View at Google Scholar
  4. J. Pretnar-Oblak, M. Zaletel, M. Jagodic, and M. Zaletel, “Thrombosis of internal carotid artery after cisplatin-based chemotherapy,” European Neurology, vol. 57, no. 2, pp. 109-110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Joseph, B. Dubashi, B. Karthikeyan, and A. Jain, “Arterial occlusion precipitated by cisplatinbased chemotherapy,” Current Oncology, vol. 17, no. 6, pp. 71-72, 2010. View at Google Scholar · View at Scopus
  6. K. Dieckmann and R. Gehrckens, “Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report,” BMC Cancer, vol. 9, no. 1, 2009. View at Publisher · View at Google Scholar
  7. A. J. Santos, S. M. Fleury Malheiros, L. R. Rodrigues Borges, C. Dzik, D. G. Nalli, and A. A. Gabbai, “Ischemic stroke after chemotherapy with cisplatin, etoposide and bleomycin: Case report,” Arquivos de Neuro-Psiquiatria, vol. 61, no. 1, pp. 129–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Ito, J. Shiraishi, T. Nakamura et al., “Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy,” Heart and Vessels, vol. 27, no. 6, pp. 634–638, 2012. View at Publisher · View at Google Scholar
  9. E. Cheng, D. R. Berthold, M. J. Moore, and I. Duran, “Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors,” Acta Oncologica, vol. 48, no. 3, pp. 475-476, 2009. View at Publisher · View at Google Scholar
  10. O. Kostek, M. B. Hacioglu, S. Orman et al., “A rare cause of acute kidney injury: renal arterial thrombosis in a small cell lung cancer patient,” Eurasian Journal of Medicine and Oncology, vol. 1, no. 1, pp. 41–43, 2017. View at Google Scholar
  11. W. Qi, F. Lin, Y. Sun, L. Tang, Z. Shen, and Y. Yao, “Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis,” British Journal of Clinical Pharmacology, vol. 76, no. 3, pp. 338–347, 2013. View at Publisher · View at Google Scholar
  12. G. Numico, O. Garrone, V. Dongiovanni et al., “Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine,” Cancer, vol. 103, no. 5, pp. 994–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Crump, T. Baetz, S. Couban et al., “Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG),” Cancer, vol. 101, no. 8, pp. 1835–1842, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Valle, H. Wasa, D. H. Palmer et al., “Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer,” The New England Journal of Medicine, vol. 362, no. 14, pp. 1273–1281, 2010. View at Publisher · View at Google Scholar